Navigation Links
2008 Ocean Sciences Meeting -- media advisory 2
Date:2/29/2008

1. Press Conference Schedule

The following schedule of press conferences is subject to change, before or during the Ocean Sciences Meeting. Press conferences may be added or dropped, their titles and emphases may change, and participants may change. All updates to this schedule will be announced in the Press Room (W307D, West Building, Orange County Convention Center). Press conferences take place in the Press Room. The times listed below are Eastern Standard Time.

Human impacts on coastal ecosystems
Monday, 3 March
1200

Ecosystems that encompass watersheds and their coastal receiving waters are under particular threat from human impact. New findings show how nutrient inputs from rivers into the most productive areas of the global ocean, called marginal seas, make those seas vulnerable to damming, land-use practices, and increasing world population. Other research indicates that the long-term sustainability of deltas is generally compromised more by large-scale engineering projectswhich result in shoreline erosion, threatened mangroves and wetlands, and increased salinization of cultivated landthan by sea-level rise. New studies of bays offer insights about phosphorus ranging from why Florida Bay has seagrass-killing algal blooms despite extremely low phosphorus from the Everglades to evidence from the Chesapeake Bay watershed that 90 percent of the human-related phosphorus inputs are retained in the watershed.

Participants:

Christophe Bernard, Bjerknes Centre for Climate Research, University of Bergen, Bergen, Norway

Marguerite Koch, Professor, Department of Biology, Florida Atlantic University, Boca Raton, Florida, USA

Christopher J. Madden, Lead Scientist, Southern Everglades/Florida Bay, SFWMD-Everglades Division, West Palm Beach, Florida, USA

Marc Russell, U.S. Environmental Protection Agency, Gulf Breeze, Florida, USA

James Syvitski, Professor & Execu
'/>"/>

Contact: Peter Weiss
pweiss@agu.org
202-777-7507
American Geophysical Union
Source:Eurekalert

2

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related biology news :

1. TAU scientists probe deep questions aboard EcoOceans environmental research ship
2. NASA celebrates a decade observing climate impacts on health of worlds oceans
3. CO2 emissions could violate EPA ocean-quality standards within decades
4. NASA celebrates a decade observing climate impacts on health of worlds oceans
5. Scientists, policymakers and industry leaders gather to discuss ocean iron fertilization
6. Acid oceans warning
7. Scientists gather in New Zealand to share oceans secrets
8. Unprecedented global measurement network achieves full coverage of oceans
9. Abel to receive posthumous Ocean and Coastal Leadership award
10. Human safety, prosperity depend on better ocean observing system: Scientists
11. Marine scientists warn human safety, prosperity depend on better ocean observing system
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology News(10 mins):Einstein receives high-risk/high-reward cancer research funding 2Einstein receives high-risk/high-reward cancer research funding 3Texas AgriLife researchers helping 2Texas AgriLife researchers helping 3Texas AgriLife researchers helping 4Jatropha Couple Oil Crop Cultivation Technology Commercially Released 13320 1Jatropha Couple Oil Crop Cultivation Technology Commercially Released 13320 2Jatropha Couple Oil Crop Cultivation Technology Commercially Released 13320 3Innovator 26apos 3Bs Studio offers Social Media Strategy Intensive Sept 16 17 2009 53443 1Innovator 26apos 3Bs Studio offers Social Media Strategy Intensive Sept 16 17 2009 53443 2Innovator 26apos 3Bs Studio offers Social Media Strategy Intensive Sept 16 17 2009 53443 3Shire Reports Positive Results From First of Three Phase III Trials of velaglucerase alfa for Type 1 Gaucher Disease and Provides Important Updates on 4809 1Shire Reports Positive Results From First of Three Phase III Trials of velaglucerase alfa for Type 1 Gaucher Disease and Provides Important Updates on 4809 2Shire Reports Positive Results From First of Three Phase III Trials of velaglucerase alfa for Type 1 Gaucher Disease and Provides Important Updates on 4809 3Shire Reports Positive Results From First of Three Phase III Trials of velaglucerase alfa for Type 1 Gaucher Disease and Provides Important Updates on 4809 4Shire Reports Positive Results From First of Three Phase III Trials of velaglucerase alfa for Type 1 Gaucher Disease and Provides Important Updates on 4809 5
Breaking Biology Technology:BioLife Solutions Announces Custom cGMP Manufacturing & License Agreement 2BioLife Solutions Announces Custom cGMP Manufacturing & License Agreement 3RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 2RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 3RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 4RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 5RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 6BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 2BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 3BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5